Abstract
Background
Although adjunctive postoperative 5-fluorouracil (5-FU) injections are known to improve the success rate of glaucoma surgery, it is still unknown what dose, timing and frequency of application will give the best results with respect to the inhibition of postoperative scarring and intraocular pressure regulation. We therefore designed the following retrospective investigation.
Methods
We studied 172 eyes from 172 patients who had undergone trabeculectomy with adjuvant 5-FU-therapy. Variations of dosage, timing and frequency were analysed retrospectively. Surgery was defined as a complete success when the patient reached an intraocular pressure under 21 mmHg and a reduction of 20% 12 months after the operation. A relative success was achieved with these criteria under additional local medication. Not reaching these postoperative criteria for a complete success was classified as failure.
Results
On average, adjunctive 5-FU-treatment was started 4.6±5.85 days postoperatively. The injections contained between 2 mg and 5 mg FU, and the mean total dose was 26.6±13.2 mg (range 5–65 mg). Surgery on 94 patients (54.65%) was classified as “complete success”, that on 25 patients (14.53%) was classified as “relative success” and that on 53 eyes (30.81%) was classified as “failure” 12 months (±3 months) postoperatively. The best results were obtained when the treatment started on or before the first postoperative day (68.0–71.4% complete success; P<0.05). In contrast, an increase in 5-FU dosage did not result in an increased success rate of trabeculectomy. None of the 172 patients suffered from vision-threatening complications such as endophthalmitis or hypotony maculopathy.
Conclusion
Early treatment with 5-FU significantly increases the success rates of filtering surgery.
Similar content being viewed by others
References
Araie M, Shoji N, Shirato S, Nakano Y (1992) Postoperative subconjunctival 5-fluorouracil injections and success probability of trabeculectomy in Japanese: results of 5-year follow-up. Jpn J Ophthalmol 36:158–168
Bansal RK, Gupta A (1992) 5-Fluorouracil in trabeculectomy for patient under the age of 40 years. Ophthalmic Surg 23:278–280
Bell RW, Habib NE, O’Brien C (1997) Long-term results and complications after trabeculectomy with a single per-operative application of 5-fluorouracil. Eye 11:663–671
Ceballos EM, Beck AD, Lynn MJ (2002) Trabeculectomy with anti-proliferative agents in uveitic glaucoma. J Glaucoma 11:189–196
Goldenfeld M, Krupin T, Ruderman JM, Wong PC, Rosenberg LF, Ritch R, Liebmann JM, Gieser DK (1994) 5-Fluorouracil in initial trabeculectomy. A prospective, randomized, multicenter study. Ophthalmology 101:1024–1029
Gressel MG, Parrish RK 2nd, Folberg R (1984) 5-Fluorouracil and glaucoma filtering surgery. An animal model. Ophthalmology 91:378–383
Grierson I, Joseph J, Miller M, Day JE (1988) Wound repair: the fibroblast and inhibition of scar formation. Eye 2:135–148
Hefetz L, Keren T, Naveh N (1994) Early and late postoperative application of 5-fluorouracil following trabeculectomy in refractory glaucoma. Ophthalmic Surg 25:715–719
Heuer DK, Parrish RK 2nd, Gressel MG, Hodapp E, Desjardins DC, Skuta GL, Palmberg PF, Nevarez JA, Rockwood EJ (1986) 5-Fluorouracil and glaucoma filtering surgery. III. Intermediate follow-up of a pilot study. Ophthalmology 93:1537–1546
Heuer DK, Parrish RK 2nd, Gressel MG, Hodapp E, Palmberg PF, Anderson DR (1984) 5-Fluorouracil and glaucoma filtering surgery. II. A pilot study. Ophthalmology 91:384–394
Jampel HD, McGuigan LJ, Dunkelberger GR, L’Hernault NL, Quigley HA (1988) Cellular proliferation after experimental glaucoma filtering surgery. Arch Ophthalmol 106:89–94
Katz LJ, Cantor LB, Spaeth GL (1985) Complications of surgery in glaucoma. Early and late bacterial endophthalmitis following glaucoma filtering surgery. Ophthalmology 92:959–963
Khaw PT, Ward S, Porter A, Grierson I, Hitchings RA, Rice NS (1992) The long-term effects of 5-fluorouracil and sodium butyrate on human tenon’s fibroblasts. Invest Ophthalmol Vis Sci 33:2043–2052
Khaw PT, Doyle JW, Sherwood MB, Grierson I, Schultz G, McGorray S (1993) Prolonged localized tissue effects from 5-minute exposures to 5-fluorouracil and mitomycin C. Arch Ophthalmol 111:263–267
Krug JH, Melamed S (1990) Adjunctive use of delayed and adjustable low-dose 5-fluorouracil in refractory glaucoma. Am J Ophthalmol 109:412–418
Liebmann JM, Ritch R, Marmor M, Nunez J, Wolner B (1991) Initial 5-fluorouracil trabeculectomy in uncomplicated glaucoma. Ophthalmology 98:1036–1041
Membrey WL, Poinoosawmy DP, Bunce C, Hitchings RA (2000) Glaucoma surgery with or without adjunctive antiproliferatives in normal tension glaucoma: 1 intraocular pressure control and complications. Br J Ophthalmol 84:586–590
Mills KB (1981) Trabeculectomy: a retrospective long-term follow-up of 444 cases. Br J Ophthalmol 65:790–795
Ophir A (1991) Effects of 5-fluorouracil on proliferating fibroblasts in vivo. Exp Eye Res 53:799–803
Pfeiffer N, Grehn F (1993) 5-Fluorouracil bei Goniotrepanationen mit schlechter prognose. Ophthalmologe 90:570–573
Rockwood EJ, Parrish RK 2nd, Heuer DK, Skuta GL, Hodapp E, Palmberg PF, Gressel MG, Feuer W (1987) Glaucoma filtering surgery with 5 -fluorouracil. Ophthalmology 94:1071–1078
Rothmann RF, Liebmann JM, Ritch R (2000) Low-dose 5-fluorouracil trabeculectomy as initial surgery in uncomplicated glaucoma: long-term follow-up. Ophthalmology 107:1184–1189
Ruderman JM, Welch DB, Smith MF, Shoch DE (1987) A randomized study of 5-fluorouracil and filtration surgery. Am J Ophthalmol 104:218–224
Singh K, Mehta K, Shaikh NM, Tsai JC, Moster MR, Budenz DL, Greenfield DS, Chen PP, Cohen JS, Baerveldt GS, Shaikh S (2000) Trabeculectomy with intraoperative mitomycin C versus 5-fluorouracil: prospective randomized clinical trial. Ophthalmology 107:2305–2309
Suzuki R, Dickens CJ, Iwach AG, Hoskins HD Jr, Hetherington J Jr, Juster RP, Wong PC, Klufas MT, Leong CJ, Nguyen N (2002) Long-term follow-up of initially successful trabeculectomy with 5-fluorouracil injections. Ophthalmology 109:1921–1924
The Fluorouracil Filtering Surgery Study Group (1996) Five-year follow-up of the fluorouracil filtering surgery study. Am J Ophthalmol 121:349–366
Ticho U, Ophir A (1993) Late complications after glaucoma filtering surgery with adjunctive 5-fluorouracil. Am J Ophthalmol 115:506–510
Towler HM, McCluskey P, Shaer B, Lightman S (2000) Long-term follow-up of trabeculectomy with intraoperative 5-fluorouracil for uveitis-related glaucoma. Ophthalmology 107:1822–1828
Watanabe J, Sawaguchi S, Fukuchi T, Abe H, Zhou L (1997) Effects of mitomycin C on expression of proliferating cell nuclear antigen after filtering surgery in rabbits. Graefes Arch Clin Exp Ophthalmol 35:234–240
Weinreb RN (1987) Adjusting the dose of 5-fluorouracil after filtering surgery to minimize side effects. Ophthalmology 94:564–570
Whidesite-Michel J, Liebmann JM, Ritch R (1992) Initial 5-fluorouracil trabeculectomy in young patients. Ophthalmology 99:7–13
Wolner B, Liebmann JM, Sassani JW, Ritch R, Speaker M, Marmor M (1991) Late bleb-related endophthalmitis after trabeculectomy with adjunctive 5-fluorouracil. Ophthalmology 98:1053–1060
WuDunn D, Cantor LB, Palanca-Capistrano AM, Hoop J, Alvi NP, Finley C, Lakhani V, Burnstein A, Knotts SL (2002). A prospective randomized trial comparing intraoperative 5-fluorouracil vs mitomycin C in primary trabeculectomy. Am J Ophthalmol 134:521–528
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Reinthal, E.K., Denk, P.O., Grüb, M. et al. Dose, timing and frequency of subconjunctival 5-fluorouracil injections after glaucoma filtering surgery. Graefe's Arch Clin Exp Ophthalmol 245, 369–375 (2007). https://doi.org/10.1007/s00417-006-0406-3
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00417-006-0406-3